Hedgehog signaling in normal urothelial cells and in urothelial carcinoma cell lines

Journal of Cellular Physiology

Volumn 203, Issue 2, 2005, Pages 372-377

  Thievessen, Ingo ^a   Wolter, Marietta ^a   Prior, Andrea ^a   Seifert, Hans Helge ^a   Schulz, Wolfgang A ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DNA; EPIDERMAL GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; WNT PROTEIN;

ARTICLE; BLADDER CARCINOMA; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; GENE; GENE EXPRESSION; GENE INACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PTCH1 GENE; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSITIONAL CELL CARCINOMA; UROGENITAL TRACT TUMOR;

CARCINOMA, TRANSITIONAL CELL; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEDGEHOG PROTEINS; HUMANS; MEMBRANE PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, CELL SURFACE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; URINARY BLADDER NEOPLASMS; UROTHELIUM; VERATRUM ALKALOIDS;

ERINACEIDAE;

EID: 16344364134     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20248     Document Type: Article

References (45)

1. Aboulkassim TO, LaRue H, Lemieux P, Rousseau F, Fradet Y. 2003. Alteration of the PATCHED locus in superficial bladder cancer. Oncogene 22:2967-2971.
2. Aza-Blanc P, Lin HY, Ruiz i Altaba A, Kornberg TB. 2000. Expression of the vertebrate Gli proteins in Drosophila reveals a distribution of activator and repressor activities. Development 127:4293-4301.
3. Barnett DH, Huang HY, Wu XE, Laciak R, Shapiro E, Bushman W. 2002. The human prostate expresses sonic hedgehog during fetal development. J Urol 168:2206-2210.
4. Berman DM, Karhadkar SS, Maitra A, Montes de Oca R, Gerstenblith MR, Briggs K, Parker AR, Shimada Y, Eshleman JR, Watkins DN, Beachy PA. 2003. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425:846-851.
5. Bonifas JM, Pennymaker S, Chuang PT, McMahon AP, Williams M, Rosenthal A, De Sauvage FJ, Epstein EH, Jr. 2001. Activation of hedgehog target genes in basal carcinomas. J Invest Dermatol 116:739-742.
6. Buttitta L, Mo R, Hui CC, Fan CM. 2003. Interplays of Gli2 and Gli3 and their requirement in mediating Shh-dependent sclerotome induction. Development 130:6233-6243.
7. Cohen MM, Jr. 2003. The Hedgehog signaling network. Am J Med Genet 123A:5-28.
8. DeCamp DL, Thompson TM, de Sauvage FJ, Lerner MR. 2000. Smoothened activates Gαi-mediated signaling in frog melanophores. J Biol Chem 275: 26322-26327.
9. Florl AR, Schulz WA. 2003. Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells. Genes Chromosomes Cancer 37:141-148.
10. Freeman MR, Yoo JJ, Raab G, Soker S, Adam RM, Schneck FX, Renshaw AA, Klagsbrun M, Atala A. 1997. Heparin-binding EGF-like growth factor is an autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder. J Clin Invest 99:1028-1036.
11. Grimm MO, Jürgens B, Schulz WA, Decken K, Makri D, Schmitz-Dräger BJ. 1995. Inactivation of tumor suppressor genes and deregulation of the c-myc gene in urothelial cancer cell lines. Urol Res 23:293-300.
12. Habuchi T, Devlin J, Elder PA, Knowles MA. 1995. Detailed deletion mapping of chromosome 9q in bladder cancer: Evidence for two tumour suppressor loci. Oncogene 11:1671-1674.
13. Jia J, Tong C, Jiang J. 2003. Smoothened transduces Hedgehog signal by physically interacting with Costal2/Fused complex through its C-terminal tail. Genes Dev 17:2709-2720.
14. Kimura F, Seifert HH, Florl AR, Santourlidis S, Steinhoff C, Swiatkowski S, Mahotka C, Gerharz CD, Schulz WA. 2003. Decrease of DNA methyltransferase 1 expression relative to cell proliferation in transitional cell carcinoma. Int J Cancer 104:568-578.
15. LaRue H, Simoneau M, Aboulkassim TO, Lemieux P, Girard J, Hamed S, Hovington H, Jeannotte L, Fradet Y. 2003. The PATCHED/Sonic Hedgehog signalling pathway in superficial bladder cancer. Med Sci 19:920-925.
16. Linnenbach AJ, Pressler LB, Seng BA, Kimmel BS, Tomaszewski JE, Malkowicz SB. 1993. Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay. Hum Mol Genet 2:1407-1411.
17. McGarvey TW, Maruta Y, Tomaszewski JE, Linnenbach AJ, Malkowicz SB. 1998. PTCH gene mutations in invasive transitional cell carcinoma of the bladder. Oncogene 17:1167-1172.
18. Norris W, Neyt C, Ingham PW, Currie PD. 2000. Slow muscle induction by Hedgehog signaling in vitro. J Cell Sci 113:2695-2703.
19. Persson M, Stamataki D, te Welscher P, Andersson E, Bose J, Rüther U, Ericson J, Briscoe J. 2002. Dorsal-ventral patterning of the spinal cord requires Gli3 transcriptional repressor activity. Genes Dev 16:2865-2878.
20. Regl G, Neill GW, Eichberger T, Kasper M, Ikram MS, Koller J, Hintner H, Quinn AG, Frischauf AM, Aberger F. 2002. Human GLI2 and GLI1 are part of a positive feedback mechanism in basal cell carcinoma. Oncogene 21:5529-5539.
21. Reifenberger J, Wolter M, Weber RG, Megahed M, Ruzicka T, Lichter P, Reifenberger G. 1998. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 58:1798-1803.
22. Rieger KM, Little AF, Swart JM, Kastrinakis WV, Fitzgerald JM, Hess DT, Libertino JA, Summerhayes IC. 1995. Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression. Br J Cancer 72:683-690.
23. Ruiz i Altaba A, Sanchez P, Dahmane N. 2002. GLI and Hedgehog in cancer: Tumours, embryos and stem cells. Nat Rev Cancer 2:361-372.
24. Sasaki H, Nishizaki Y, Hui C, Nakafuku M, Kondoh H. 1999. Regulation of GH2 and Gli3 activities by an amino-terminal repression domain: Implication of GH2 and Gli3 as primary mediators of Shh signaling. Development 126:3915-3924.
25. Schulz WA, Crawford N, Locker J. 1988. Albumin and α-fetoprotein gene expression and DNA methylation in rat hepatoma cell lines. Exp Cell Res 174:433-447.
26. Shin SH, Kogerman P, Lindstrom E, Toftgard R, Biesecker LG. 1999. GLI3 mutations in human disorders mimic Drosophila cubitus interruptus protein functions and localization. Proc Natl Acad Sci USA 96:2880-2884.
27. Southgate J, Hutton KAR, Thomas DFM, Trejdosiewicz LK. 1994. Normal human urothelial cells in vitro: Proliferation and induction of stratification. Lab Invest 71:583-594.
28. Southgate J, Harnden P, Trejdosiewicz LK. 1999. Cytokeratin expression patterns in normal and malignant urothelium: A review of the biological and diagnostic implications. Histol Histopathol 14:657-664.
29. Spruck CH III, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schmutte C, Yang AS, Cote R. 1994. Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res 54:784-788.
30. Steinhoff C, Prior A, Reichmann G, Seifert HH, Schulz WA. 2002. Activity of E2F-dependent promoters in bladder carcinoma cells and their use for tumor-specific targeting of p53-induced apoptosis. Int J Oncol 21:1033-1040.
31. Stoehr R, Krieg RC, Knuechel R, Hofstaedter F, Pilarsky C, Zaak D, Schmitt R, Hartmann A. 2002. No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Int J Oncol 20:905-911.
32. Swiatkowski S, Seifert HH, Steinhoff C, Thievessen I, Schliess F, Schulz WA. 2003. Activities of MAP-kinase pathways in normal uroepithelial cells and uroepithelial carcinoma cell lines. Exp Cell Res 282:48-57.
33. Taipale J, Beachy PA. 2001. The Hedgehog and Wnt signaling pathways in cancer. Nature 411:349-354.
34. Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, Zhang X, Agatep R, Chiappa S, Gao L, Lowrance A, Hao A, Goldstein AM, Stavrou T, Scherer SW, Dura WT, Wainwright B, Squire JA, Rutka JT, Hogg D. 2002. Mutations in SUFU predispose to medulloblastoma. Nat Genet 31:306-310.
35. Thayer SP, Magliano di MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers GY, Qi YP, Gysin S, Fernandez-del Castillo C, Yainik V, Antoniu B, McMahon M, Warshaw AL, Hebrok M. 2003. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425:851-856.
36. Thievessen I, Seifert H-H, Swiatkowski S, Florl AR, Schulz WA. 2003. E-cadherin involved in inactivation of WNT/β-catenin signalling in urothelial carcinoma and normal urothelial cells. Br J Cancer 88:1932-1938.
37. Toftgard R. 2000. Hedgehog signalling in cancer. Cell Mol Life Sci 57:1720-1731.
38. Unden AB, Zaphiropoulos PG, Bruce K, Toftgard R, Stahle-Backdahl M. 1997. Human patched (PTCH) mRNA is overexpressed consistently in tumor cells of both familial and sporadic basal cell carcinomas. Cancer Res 57:2336-2340.
39. Watkins DN, Berman DM, Burkholder SG, Wang B, Beachy PA, Baylin SB. 2003. Hedgehog-signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422:313-317.
40. Williams SV, Sibley KD, Davies AM, Nishiyama H, Hornigold N, Coulter J, Kennedy WJ, Skilleter A, Habuchi T, Knowles MA. 2002. Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines. Genes Chromosomes Cancer 34:86-96.
41. Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G. 1997. Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 57:2581-2585.
42. Wu RL, Osman I, Wu XR, Lu ML, Zhang ZF, Liang FX, Hamza R, Scher H, Cordon-Cardo C, Sun TT. 1998. Uroplakin II gene is expressed in transitional cell carcinoma but not in bilharzial bladder squamous cell carcinoma: Alternative pathways of bladder epithelial differentiation and tumor formation. Cancer Res 58:1291-1297.
43. Xie J, Murone M, Luoh SM, Ryan A, Gu Q, Zhang C, Bonifas JM, Lam CW, Hynes M, Goddard A, Rosenthal A, Epstein EH, Jr, de Sauvage FJ. 1998. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391:90-92.
44. Yuasa T, Yoshiki T, Isono T, Tanaka T, Hayashida H, Okada Y. 1999. Expression of transitional cell-specific genes, uroplakin Ia and II, in bladder cancer: Detection of circulating cancer cells in the peripheral blood of metastatic patients. Int J Urol 6:286-292.
45. Zhang Y, Kalderon D. 2001. Hedgehog acts as a somatic stem cell factor in the Drosophila ovary. Nature 410:599-604.